<DOC>
	<DOCNO>NCT00404274</DOCNO>
	<brief_summary>GW679769 may affect liver enzymes metabolize warfarin . This study design test extent GW679769 affect Warfarin level human .</brief_summary>
	<brief_title>A Study Testing Effect Safety Casopitant ( GW679769 ) While Taking Warfarin Healthy Human Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Inclusion criterion : Healthy subject nonsmoking Females able child Must able swallow retain oral medication Understand sign write consent comply requirement restriction involve overnight 30 day confinement healthcare set Exclusion criterion : participate subject clinically relevant abnormality , medical condition , circumstance make unsuitable study per study doctor . blood donation excess 1 pint within 56 day dose medication iron deficiency history drug alcohol abuse dependency within past 6 month subject use nicotinecontaining product within last 6 month positive HIV , Hepatitis B C use prescription nonprescription drug ( ) , herbal dietary supplement vitamins 14 day prior first dose study medication consumption food drink contain grapefruit , Seville oranges , kumquat , pomelo ( juice ) within 7 day first dose study medication history bleed disorder excessive bleed female positive pregnancy test female lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>healthy human volunteer</keyword>
	<keyword>GW679769</keyword>
	<keyword>warfarin</keyword>
	<keyword>casopitant</keyword>
</DOC>